alexsamuel's blog
In February 2020, Indonesia starts accepting orders for the Suzuki Baleno RS. It is possible that over time the usual Suzuki Baleno will reach our country. The version with the RS prefix can be distinguished from this hatchback by a more impudent appearance. This Suzuki car relies on redesigned bumpers, a modified grille, comfortable door sills and black alloy wheels 16 inches. The Baleno RS is powered by a 102-liter Boosterjet three-cylinder turbo engine. Paired with him is a five-speed manual.
The hatchback boasts stylish head optics, LED DRLs, metal pedals, front seats with pronounced lateral support, native multimedia and much more.
Recall, Baleno leaves the assembly line of the Indian factory Maruti Suzuki. The standard hatchback is equipped with one of two available engines: a 1.2-liter naturally aspirated, producing 84 hp. or a 1.3-liter 75-horsepower turbodiesel. The cost of such a car starts at 673,611 rupees. For sports Baleno RS will have to pay a minimum of 888,913 rupees.
Karma Automotive will introduce an electric pickup truck and SUV
The approach of the brand’s engineers is to use the new all-wheel drive platform (we believe that it is completely electric), but there are no details about it yet.
In the near future, California-based Karma may move from creating sports and luxury luxury cars (currently the company only offers the hybrid Revero GT / GTS, pictured below) to all-electric pickups and SUVs.
According to an article by Bloomberg, a presentation of the concept version of the first Karma pickup is expected by the end of this year. A few months ago, the guys already hinted at the possibility of using their electric power units on larger types of cars - for example, pickups.
The approach of the brand’s engineers is to use the new all-wheel drive platform (we believe that it is completely electric), but there are no details about it yet.
Kevin Pavlov, Karma’s new COO, said: “We can bring an electric SUV and pickup to the market.” Another area of parallel brand development is the process of creating all-electric models, which were announced by the Karma SC2 concept, which debuted at the Los Angeles Auto Show.
With the support of the large Chinese concern Wanxiang Group, which acquired Karma's assets in 2014, the latter probably has the necessary resources to significantly expand its lineup.
A heart health company cardiogram and an Oscar health insurer combine to allow Oscar members to control signs of diabetes and atrial fibrillation with wearable devices.
Participants will need an Apple Watch , Garmin, or Wear OS smartwatch to use the Cardiogram app, which will monitor for signs of both conditions in the background as users do their business day after day. If the device detects symptoms of any of them, users will receive a warning to receive confirmatory tests of a medical level, either a blood test in a nearby laboratory for diabetes, or a mobile ECG test (sent by mail) for atrial fibrillation.
These tests will be free, and if they confirm that the patients have a tendency to the disease, a cardiogram will help them take the next step to treatment.
Last year, as part of a study with researchers at UC San Francisco, a cardiogram confirmed that it can detect diabetes using modern wearable devices. This is the first time he has conducted this research in practice.
Co-founder Brandon Ballinger said they are currently receiving 97% accuracy for AFib and 85% for diabetes. However, it does not have FDA approval for both, and does not look to receive it. That's why it plays a more advisory role, encouraging users to look for confirmatory tests if it detects suspicious symptoms. According to Ballinger, the cardiogram will need to analyze at least one week of data before making any recommendations.
As for the future development of AFib tracking in the future, Ballinger suggests that the cardiogram may lean back from the FDA-approved Apple Watch ECG — if Apple ever makes the API available to developers. At the moment, he relies entirely on optical data.
“I think, based on the conditions that we do, you will always want to do standard medical tests,” Ballinger told me over the phone. “Not just for the purposes of the FDA, but also for how your doctor is going to interpret the results.”
This is not the first time we see technology companies teaming up with healthcare providers. This year, Apple partnered with Aetna, rewarding Apple Watch patients for healthy behavior. Fitbit also created several of its own partnerships. But the cardiogram and the Oscars come together in a way that we have not seen before, giving healthcare members the ability to view for specific conditions.
While the Apple Watch can track the signs of AFib itself, diabetes monitoring is a completely different game. People with diabetes often have low heart rate variability, which is one of the key factors that the cardiogram keeps an eye on.
As for how profitable it is, Oscar - the provider competes in the Obamacare market, where there is an incentive program that pays insurers for each member who receives the diagnosis. And Oscar pays a cardiogram to use its technology.
“The next step is to get out of the lab and sit on your wrist,” said Ballinger. Oscar healthcare members can download the Cardiogram app and link their bills starting today.